Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 11:59 am Purchase |
2024-12-31 | 13G | Precision BioSciences, Inc. DTIL |
Aquilo Capital Management LLC | 791,862 9.900% |
791,862 (New Position) |
Filing History |
| 2024-03-18 5:28 pm Purchase |
2024-03-01 | 13G | Precision BioSciences, Inc. DTIL |
Aquilo Capital Management LLC | 662,659 9.900% |
662,659 (New Position) |
Filing History |
| 2024-02-14 4:37 pm Sale |
2023-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Aquilo Capital Management LLC | 14,085 1.100% |
-56,911 (-80.16%) |
Filing History |
| 2023-02-14 11:28 am Purchase |
2022-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Aquilo Capital Management LLC | 70,995 7.500% |
16,954 (+31.37%) |
Filing History |
| 2023-02-14 11:16 am Sale |
2022-12-31 | 13G | Spero Therapeutics, Inc. SPRO |
Aquilo Capital Management LLC | 0 0.000% |
-3,419,435 (Position Closed) |
Filing History |
| 2023-02-14 11:12 am Sale |
2022-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
Aquilo Capital Management LLC | 0 0.000% |
-3,155,082 (Position Closed) |
Filing History |
| 2022-10-03 4:40 pm Sale |
2022-09-22 | 13G | Spero Therapeutics, Inc. SPRO |
Aquilo Capital Management LLC | 3,419,435 9.800% |
-1,602,101 (-31.90%) |
Filing History |
| 2022-03-08 5:41 pm Purchase |
2022-01-18 | 13G | Spero Therapeutics, Inc. SPRO |
Aquilo Capital Management LLC | 5,021,536 15.500% |
57,355 (+1.16%) |
Filing History |
| 2022-02-14 3:54 pm Purchase |
2021-12-31 | 13G | Spero Therapeutics, Inc. SPRO |
Aquilo Capital Management LLC | 4,964,181 15.400% |
1,031,972 (+26.24%) |
Filing History |
| 2022-02-14 3:20 pm Sale |
2021-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Aquilo Capital Management LLC | 54,041 5.900% |
-5,988 (-9.97%) |
Filing History |
| 2022-02-14 3:09 pm Purchase |
2021-12-31 | 13G | Magenta Therapeutics, Inc. MGTA |
Aquilo Capital Management LLC | 3,155,082 5.400% |
3,155,082 (New Position) |
Filing History |
| 2021-02-16 4:13 pm Sale |
2020-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS |
Aquilo Capital Management LLC | 60,029 8.400% |
-9,665 (-13.87%) |
Filing History |
| 2021-02-16 4:00 pm Sale |
2020-12-31 | 13G | Spero Therapeutics, Inc. SPRO |
Aquilo Capital Management LLC | 3,932,209 14.500% |
-564,933 (-12.56%) |
Filing History |
| 2020-09-22 6:51 pm Purchase |
2020-09-11 | 13G | Spero Therapeutics, Inc. SPRO |
Aquilo Capital Management LLC | 4,497,142 17.400% |
3,342,786 (+289.58%) |
Filing History |